三唑类作为生物电子等排体和连接子在微管靶向剂研发中的应用。
Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents.
作者信息
Malik M Shaheer, Ahmed Saleh A, Althagafi Ismail I, Ansari Mohammed Azam, Kamal Ahmed
机构信息
Department of Chemistry , Faculty of Applied Sciences , Umm Al-Qura University , 21955 Makkah , Saudi Arabia . Email:
Central Research Laboratories , Faculty of Applied Sciences , Umm Al-Qura University , 21955 Makkah , Saudi Arabia.
出版信息
RSC Med Chem. 2020 Jan 29;11(3):327-348. doi: 10.1039/c9md00458k. eCollection 2020 Mar 1.
Abstract
The triazole ring system has emerged as an exciting prospect in the optimization studies of promising lead molecules in the quest for new drugs for clinical usage. Several marketed drugs possess these versatile moieties that are used in a wide range of medical indications. This stems from the unique intrinsic properties of triazoles, which impart stability to the basic pharmacophoric unit with an added advantage of being a bioisostere of different chemical functionalities. In the last decade, the use of triazoles as bioisosteres and linkers in the development of microtubule targeting agents has been extensively investigated. The present review highlights the advances in this promising area of drug discovery and development.
摘要
在寻找临床应用新药的过程中，三唑环系统已成为有前景的先导分子优化研究中的一个令人兴奋的前景。几种上市药物含有这些多功能部分，用于广泛的医学适应症。这源于三唑独特的内在性质，它赋予基本药效基团稳定性，还有作为不同化学功能生物电子等排体的额外优势。在过去十年中，三唑作为生物电子等排体和连接子在微管靶向剂开发中的应用已得到广泛研究。本综述重点介绍了这一有前景的药物发现和开发领域的进展。
相似文献
1
Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents.
RSC Med Chem. 2020 Jan 29;11(3):327-348. doi: 10.1039/c9md00458k. eCollection 2020 Mar 1.
2
The application of bioisosteres in drug design for novel drug discovery: focusing on acid protease inhibitors.
Expert Opin Drug Discov. 2012 Oct;7(10):903-22. doi: 10.1517/17460441.2012.712513. Epub 2012 Aug 8.
3
The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool.
Expert Opin Drug Discov. 2022 Nov;17(11):1209-1236. doi: 10.1080/17460441.2022.2129613. Epub 2022 Oct 5.
4
Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
Bioorg Med Chem Lett. 2013 Aug 15;23(16):4528-31. doi: 10.1016/j.bmcl.2013.06.045. Epub 2013 Jun 26.
5
Average Electron Density: A Quantitative Tool for Evaluating Non-Classical Bioisosteres of Amides.
ACS Omega. 2024 Mar 5;9(11):13172-13182. doi: 10.1021/acsomega.3c09732. eCollection 2024 Mar 19.
6
The 1,2,3-triazole ring as a bioisostere in medicinal chemistry.
Drug Discov Today. 2017 Oct;22(10):1572-1581. doi: 10.1016/j.drudis.2017.05.014. Epub 2017 Jul 1.
7
Structural Consequences of the 1,2,3-Triazole as an Amide Bioisostere in Analogues of the Cystic Fibrosis Drugs VX-809 and VX-770.
ChemMedChem. 2020 Sep 16;15(18):1720-1730. doi: 10.1002/cmdc.202000220. Epub 2020 May 26.
8
Significance of Triazole in Medicinal Chemistry: Advancement in Drug Design, Reward and Biological Activity.
Chem Biodivers. 2024 Jul;21(7):e202400637. doi: 10.1002/cbdv.202400637. Epub 2024 Jun 26.
9
Recent Progress in 1H-1,2,3-triazoles as Potential Antifungal Agents.
Curr Top Med Chem. 2021;21(23):2109-2133. doi: 10.2174/1568026621666210913122828.
10
Evaluation of 1,2,3-Triazoles as Amide Bioisosteres In Cystic Fibrosis Transmembrane Conductance Regulator Modulators VX-770 and VX-809.
Chemistry. 2019 Mar 7;25(14):3662-3674. doi: 10.1002/chem.201805919. Epub 2019 Feb 11.
引用本文的文献
1
Pharmacological Evaluation of Bioisosterically Replaced and Triazole- Tethered Derivatives for Anticancer Therapy.
Med Chem. 2025;21(4):264-293. doi: 10.2174/0115734064320533240903062533.
2
Design, synthesis and evaluations of new cyclotriphosphazenes as safe drug candidates.
RSC Med Chem. 2025 Feb 12. doi: 10.1039/d4md00885e.
3
Synthesis of enantiomerically enriched β-substituted analogs of (S)-α-alanine containing 1-phenyl-1H-1,2,3-triazole groups.
Amino Acids. 2024 Dec 3;56(1):67. doi: 10.1007/s00726-024-03430-5.
4
An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential.
Mol Divers. 2025 Feb;29(1):899-964. doi: 10.1007/s11030-024-10858-0. Epub 2024 Jul 27.
5
Unveiling the anti-echinococcal efficacy of amide-based compounds: An and study.
Heliyon. 2024 May 14;10(10):e31205. doi: 10.1016/j.heliyon.2024.e31205. eCollection 2024 May 30.
6
Average Electron Density: A Quantitative Tool for Evaluating Non-Classical Bioisosteres of Amides.
ACS Omega. 2024 Mar 5;9(11):13172-13182. doi: 10.1021/acsomega.3c09732. eCollection 2024 Mar 19.
7
Identified Isosteric Replacements of Ligands' Glycosyl Domain by Data Mining.
ACS Omega. 2023 Jul 5;8(28):25165-25184. doi: 10.1021/acsomega.3c02243. eCollection 2023 Jul 18.
8
Identification of multidentate tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors that simultaneously access the DNA, protein and catalytic-binding sites by oxime diversification.
RSC Chem Biol. 2023 Mar 27;4(5):334-343. doi: 10.1039/d2cb00230b. eCollection 2023 May 10.
9
Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma.
Int J Mol Sci. 2023 Mar 23;24(7):6028. doi: 10.3390/ijms24076028.
10
Thermo-Responsive Polymer-siRNA Conjugates Enabling Artificial Control of Gene Silencing around Body Temperature.
Pharm Res. 2023 Jan;40(1):157-165. doi: 10.1007/s11095-022-03414-8. Epub 2022 Oct 28.
本文引用的文献
1
Antibacterial activity study of 1,2,4-triazole derivatives.
Eur J Med Chem. 2019 Jul 1;173:274-281. doi: 10.1016/j.ejmech.2019.04.043. Epub 2019 Apr 16.
2
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Eur J Med Chem. 2019 Apr 15;168:357-372. doi: 10.1016/j.ejmech.2019.02.055. Epub 2019 Feb 22.
3
Synthesis and antimicrobial activity of novel 1,2,3-triazole-conjugates of quinazolin-4-ones.
Arch Pharm (Weinheim). 2019 Mar;352(3):e1800302. doi: 10.1002/ardp.201800302. Epub 2019 Jan 30.
4
New Endpoints, Programs Used for Drug Approvals.
Cancer Discov. 2019 Feb;9(2):160. doi: 10.1158/2159-8290.CD-NB2019-010. Epub 2019 Jan 25.
5
Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
Int J Antimicrob Agents. 2019 May;53(5):612-619. doi: 10.1016/j.ijantimicag.2019.01.010. Epub 2019 Jan 23.
6
Microtubules: From understanding their dynamics to using them as potential therapeutic targets.
J Cell Physiol. 2019 Jun;234(6):7923-7937. doi: 10.1002/jcp.27978. Epub 2018 Dec 10.
7
Synthesis and Biological Profiles of 1,2,3-Triazole Scaffold.
Curr Top Med Chem. 2018;18(17):1426-1427. doi: 10.2174/156802661817181107151553.
8
Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents.
Bioorg Chem. 2019 Mar;83:535-548. doi: 10.1016/j.bioorg.2018.11.002. Epub 2018 Nov 3.
9
Sea Urchin Embryo Model As a Reliable in Vivo Phenotypic Screen to Characterize Selective Antimitotic Molecules. Comparative evaluation of Combretapyrazoles, -isoxazoles, -1,2,3-triazoles, and -pyrroles as Tubulin-Binding Agents.
ACS Comb Sci. 2018 Dec 10;20(12):700-721. doi: 10.1021/acscombsci.8b00113. Epub 2018 Nov 29.
10
Design and Synthesis of Novel Sulfonamide-Derived Triazoles and Bioactivity Exploration.
Med Chem. 2020;16(1):104-118. doi: 10.2174/1573406414666181106124852.
Zotero 插件